{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:49:04Z","timestamp":1792669744407,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is mounting evidence that microscopically positive (R1) margins in patients with colorectal cancer (CRC) may represent a surrogate for aggressive cancer biology rather than technical failure during surgery. However, whether detectable biological differences exist between CRC with R0 and R1 margins is unknown. We sought to investigate whether mismatch repair (MMR) status differs between Stage III CRC with R0 or R1 margins.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients treated for Stage III CRC from January 1, 2016 to December 31, 2019 were identified by using the Danish Colorectal Cancer Group database. Patients were stratified according to MMR status (proficient [pMMR] vs. deficient [dMMR]) and margin status. Outcomes of interest included the R1 rate according to MMR and overall survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 3636 patients were included, of whom 473 (13.0%) had dMMR colorectal cancers. Patients with dMMR cancers were more likely to be elderly, female, and have right-sided cancers. R1 margins were significantly more common in patients with dMMR cancers (20.5% vs. 15.2%, <jats:italic>p<\/jats:italic> &lt; 0.001), with the greatest difference seen in the rate of R1 margins related to the primary tumour (8.9% vs. 4.7%) rather than to lymph node metastases (11.6% vs. 10.5%). This association was seen in both right- and left-sided cancers. On multivariable analyses, R1 margins, but not MMR status, were associated with poorer survival, alongside age, pN stage, perineural invasion, and extramural venous invasion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In patients with Stage III CRC, dMMR status is associated with increased risks of R1 margins following potentially curative surgery, supporting the use of neoadjuvant immunotherapy in this patient group.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-024-15595-0","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:05:17Z","timestamp":1718985917000},"page":"6423-6431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Association of Mismatch Repair Status with Microscopically Positive (R1) Margins in Stage III Colorectal Cancer: A Retrospective Cohort Study"],"prefix":"10.1245","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4218-4648","authenticated-orcid":false,"given":"Henry G.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nis H.","family":"Schlesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepthi","family":"Chiranth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Qvortrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"issue":"3","key":"15595_CR1","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1097\/SLA.0000000000005051","volume":"275","author":"MB Loughrey","year":"2022","unstructured":"Loughrey MB, Webster F, Arends MJ, Brown I, Burgart LJ, Cunningham C, et al. Dataset for pathology reporting of colorectal cancer: recommendations from the international collaboration on cancer reporting (ICCR). Ann Surg. 2022;275(3):e549\u201361.","journal-title":"Ann Surg."},{"key":"15595_CR2","doi-asserted-by":"crossref","unstructured":"Bernstein TE, Endreseth BH, Romundstad P, Wibe A, Norwegian Colorectal Cancer G. Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg. 2009;96(11):1348-57.","DOI":"10.1002\/bjs.6739"},{"issue":"4","key":"15595_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/00000658-200204000-00001","volume":"235","author":"KF Birbeck","year":"2002","unstructured":"Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235(4):449\u201357.","journal-title":"Ann Surg."},{"issue":"3","key":"15595_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/00000478-200203000-00009","volume":"26","author":"ID Nagtegaal","year":"2002","unstructured":"Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH, Pathology Review C, Cooperative Clinical I. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol. 2002;26(3):350\u20137.","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"15595_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1046\/j.0007-1323.2001.02024.x","volume":"89","author":"A Wibe","year":"2002","unstructured":"Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Soreide O. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg. 2002;89(3):327\u201334.","journal-title":"Br J Surg."},{"issue":"9","key":"15595_CR6","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamasurg.2015.1525","volume":"150","author":"R Amri","year":"2015","unstructured":"Amri R, Bordeianou LG, Sylla P, Berger DL. Association of radial margin positivity with colon cancer. JAMA Surg. 2015;150(9):890\u20138.","journal-title":"JAMA Surg."},{"issue":"6","key":"15595_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/SLA.0000000000004682","volume":"276","author":"MA Healy","year":"2022","unstructured":"Healy MA, Peacock O, Hu CY, Bednarski BK, Tillman MM, Messick C, et al. High rate of positive circumferential resection margin in colon cancer: a national appraisal and call for action. Ann Surg. 2022;276(6):1023\u20138.","journal-title":"Ann Surg."},{"issue":"11","key":"15595_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/codi.12960","volume":"17","author":"MA Khan","year":"2015","unstructured":"Khan MA, Hakeem AR, Scott N, Saunders RN. Significance of R1 resection margin in colon cancer resections in the modern era. Colorectal Dis. 2015;17(11):943\u201353.","journal-title":"Colorectal Dis."},{"issue":"8","key":"15595_CR9","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/BF02237384","volume":"41","author":"NR Hall","year":"1998","unstructured":"Hall NR, Finan PJ, Al-Jaberi T, Tsang CS, Brown SR, Dixon MF, Quirke P. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum. 1998;41(8):979\u201383.","journal-title":"Dis Colon Rectum."},{"issue":"2","key":"15595_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1200\/JCO.2007.12.7027","volume":"26","author":"ID Nagtegaal","year":"2008","unstructured":"Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26(2):303\u201312.","journal-title":"J Clin Oncol."},{"issue":"4","key":"15595_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/codi.16459","volume":"25","author":"HG Smith","year":"2023","unstructured":"Smith HG, Chiranth DJ, Schlesinger NH. Do differences in surgical quality account for the higher rate of R1 margins to lymph node metastases in right- versus left-sided Stage III colon cancer: a retrospective cohort study. Colorectal Dis. 2023;25(4):679\u201387.","journal-title":"Colorectal Dis."},{"issue":"2","key":"15595_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/codi.15971","volume":"24","author":"HG Smith","year":"2022","unstructured":"Smith HG, Chiranth D, Mortensen CE, Schlesinger NH. The significance of subdivisions of microscopically positive (R1) margins in colorectal cancer: a retrospective study of a national cancer registry. Colorectal Dis. 2022;24(2):197\u2013209.","journal-title":"Colorectal Dis."},{"issue":"7","key":"15595_CR13","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/codi.16121","volume":"24","author":"HG Smith","year":"2022","unstructured":"Smith HG, Skovgaards DM, Chiranth D, Schlesinger NH. The impact of subdivisions of microscopically positive (R1) margins on patterns of relapse in stage III colorectal cancer\u2014a retrospective cohort study. Colorectal Dis. 2022;24(7):828\u201337.","journal-title":"Colorectal Dis."},{"issue":"6","key":"15595_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/0284186X.2023.2218555","volume":"62","author":"HG Smith","year":"2023","unstructured":"Smith HG, Skovgaards DM, Bui NH, Chiranth D, Qvortrup C, Schlesinger NH. Differences in adjuvant chemotherapy and oncological outcomes according to margin status in patients with stage III colon cancer. Acta Oncol. 2023;62(6):594\u2013600.","journal-title":"Acta Oncol."},{"issue":"6","key":"15595_CR15","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1200\/JCO.2003.04.060","volume":"21","author":"P Peltomaki","year":"2003","unstructured":"Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol. 2003;21(6):1174\u20139.","journal-title":"J Clin Oncol."},{"issue":"3","key":"15595_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/JCO.2005.01.086","volume":"23","author":"S Popat","year":"2005","unstructured":"Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23(3):609\u201318.","journal-title":"J Clin Oncol."},{"issue":"20","key":"15595_CR17","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","volume":"28","author":"DJ Sargent","year":"2010","unstructured":"Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28(20):3219\u201326.","journal-title":"J Clin Oncol."},{"issue":"10","key":"15595_CR18","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argiles","year":"2020","unstructured":"Argiles G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T, et al. Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(10):1291\u2013305.","journal-title":"Ann Oncol."},{"issue":"25","key":"15595_CR19","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","volume":"386","author":"A Cercek","year":"2022","unstructured":"Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M, et al. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med. 2022;386(25):2363\u201376.","journal-title":"N Engl J Med."},{"issue":"4","key":"15595_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. 2020;26(4):566\u201376.","journal-title":"Nat Med."},{"issue":"26","key":"15595_CR21","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med. 2015;372(26):2509\u201320.","journal-title":"N Engl J Med."},{"issue":"4","key":"15595_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139.","journal-title":"J Clin Epidemiol."},{"issue":"12","key":"15595_CR23","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1111\/codi.15352","volume":"22","author":"Klein MF, Gogenur I, Ingeholm P, Njor SH, Iversen LH, Emmertsen KJ, Group DV","year":"2020","unstructured":"Klein MF, Gogenur I, Ingeholm P, Njor SH, Iversen LH, Emmertsen KJ, Group DV. Validation of the danish colorectal cancer group (DCCG.dk) database - on behalf of the Danish Colorectal Cancer Group. Colorectal Dis. 2020;22(12):2057\u201367.","journal-title":"Colorectal Dis."},{"issue":"9","key":"15595_CR24","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/jnci\/djy004","volume":"110","author":"GC Liu","year":"2018","unstructured":"Liu GC, Liu RY, Yan JP, An X, Jiang W, Ling YH, et al. The heterogeneity between lynch-associated and sporadic MMR deficiency in colorectal cancers. J Natl Cancer Inst. 2018;110(9):975\u201384.","journal-title":"J Natl Cancer Inst."},{"issue":"8","key":"15595_CR25","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1200\/JCO.22.00046","volume":"41","author":"D Morton","year":"2023","unstructured":"Morton D, Seymour M, Magill L, Handley K, Glasbey J, Glimelius B, et al. Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial. J Clin Oncol. 2023;41(8):1541\u201352.","journal-title":"J Clin Oncol."},{"issue":"1","key":"15595_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00384-017-2932-3","volume":"33","author":"ML Malmstrom","year":"2018","unstructured":"Malmstrom ML, Brisling S, Klausen TW, Saftoiu A, Perner T, Vilmann P, Gogenur I. Staging with computed tomography of patients with colon cancer. Int J Colorectal Dis. 2018;33(1):9\u201317.","journal-title":"Int J Colorectal Dis."},{"issue":"4","key":"15595_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/SLA.0000000000003454","volume":"271","author":"M Karoui","year":"2020","unstructured":"Karoui M, Rullier A, Piessen G, Legoux JL, Barbier E, De Chaisemartin C, et al. Perioperative FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a phase II multicenter randomized controlled trial (PRODIGE 22). Ann Surg. 2020;271(4):637\u201345.","journal-title":"Ann Surg."},{"issue":"4_Suppl","key":"15595_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1200\/JCO.2022.40.4_suppl.181","volume":"40","author":"D Vinal","year":"2022","unstructured":"Vinal D, Martinez-Perez D, Mart\u00ednez-Recio S, Ruiz I, Jimenez Bou D, Pena J, et al. Clinicopathological characteristics and outcomes of patients with deficient mismatch repair colorectal cancer. J Clin Oncol. 2022;40(4_Suppl):181.","journal-title":"J Clin Oncol."},{"key":"15595_CR29","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.3507","author":"DJ Sargent","year":"2014","unstructured":"Sargent DJ, Shi Q, Yothers G, Tejpar S, Bertagnolli MM, Thibodeau SN, et al. Prognostic impact of deficient mismatch repair (dMMR) in 7803 stage II\/III colon cancer (CC) patients (pts): a pooled individual pt data analysis of 17 adjuvant trials in the ACCENT database. J Clin Oncol. 2014. https:\/\/doi.org\/10.1200\/jco.2014.32.15_suppl.3507.","journal-title":"J Clin Oncol"},{"issue":"1","key":"15595_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/cge.13628","volume":"97","author":"Z Deng","year":"2020","unstructured":"Deng Z, Qin Y, Wang J, Wang G, Lang X, Jiang J, et al. Prognostic and predictive role of DNA mismatch repair status in stage II-III colorectal cancer: a systematic review and meta-analysis. Clin Genet. 2020;97(1):25\u201338.","journal-title":"Clin Genet."},{"issue":"1","key":"15595_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12957-019-1706-5","volume":"17","author":"B Wang","year":"2019","unstructured":"Wang B, Li F, Zhou X, Ma Y, Fu W. Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis. World J Surg Oncol. 2019;17(1):169.","journal-title":"World J Surg Oncol."},{"issue":"20","key":"15595_CR32","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1158\/1078-0432.CCR-14-0332","volume":"20","author":"S Venderbosch","year":"2014","unstructured":"Venderbosch S, Nagtegaal ID, Maughan TS, Smith CG, Cheadle JP, Fisher D, et al. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies. Clin Cancer Res. 2014;20(20):5322\u201330.","journal-title":"Clin Cancer Res."},{"issue":"9","key":"15595_CR33","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/sj.bjc.6602534","volume":"92","author":"A Buckowitz","year":"2005","unstructured":"Buckowitz A, Knaebel HP, Benner A, Blaker H, Gebert J, Kienle P, et al. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer. 2005;92(9):1746\u201353.","journal-title":"Br J Cancer."},{"issue":"6349","key":"15595_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409\u201313.","journal-title":"Science"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15595-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15595-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15595-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T14:24:08Z","timestamp":1726755848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15595-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["15595"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15595-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"This study was approved by the Danish Patient Safety Authority (R-20061154) and the Danish Data Protection Agency (P-2020-902).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}